Principal Investigators in the Metabolic Epidemiology Branch (MEB)

Dr. Abnet's work focuses on the etiology of esophageal and gastric cancer and the oral microbiome. His research interests are driven by a desire to meet the needs of populations in limited-resource settings who are at highest risk for these diseases.

Dr. Demetrius Albanes conducts molecular epidemiologic research focused on prostate and other cancers in relation to micronutrients (particularly vitamins D, E, and A), vitamin supplementation, and metabolite profiles through biochemical, genetic, and mechanistic investigations.

Dr. Camargo maintains a robust research program with a multidisciplinary team of international collaborators applying cutting-edge molecular epidemiology to the study of H. pylori, premalignant and malignant gastric lesions, and studies to evaluate the role of infections and potential biomarkers for screening for esophageal cancer.

Erikka Loftfield investigates the interplay between diet, metabolism, the microbiome and genetics and their effects on cancer risk. Her integrative research program leverages developing technologies to clarify diet-cancer associations. She is an Earl Stadtman Tenure-Track Investigator in the Metabolic Epidemiology Branch.

Dr. Matthews studies the relationship between the full spectrum of physical activity behaviors and cancer risk, including the dose-response and biological mechanisms underlying these relationships. He is working to develop better methods and tools for measuring physical activity behaviors in population-based studies. This knowledge is critical to the development of evidence-based public health guidelines for physical activity and cancer prevention and control.

Dr. Katherine McGlynn uses a variety of study designs to investigate environmental and genetic risk factors that may contribute to increasing rates of both testicular cancer and primary liver cancer in many populations.

Dr. Steven C. Moore investigates how physical activity, obesity, and diet are related to human carcinogenesis and health. He explores these associations through analyses of large-scale consortium datasets and high-throughput molecular epidemiology studies. Dr. Moore is the principal investigator for the Prostate, Lung, Colon, and Ovary (PLCO)  Cohort Study. 

Rashmi Sinha conducts interdisciplinary research to elucidate the dietary exposures and biological mechanisms associated with cancer risk, including the role of the microbiome.

Rachael Stolzenberg-Solomon has focused much of her research on elucidating the etiology of pancreatic cancer, the third leading cause of cancer mortality in the U.S. She has examined dietary, other lifestyle, genetic, and infectious factors, including biomarkers that may help reveal underlying mechanisms of carcinogenesis.

Dr. Vogtmann’s research focuses on: the association between the human microbiome and cancer risk; and evaluation of methods for collection, storage, and processing of samples and data for study of the human microbiome.